CSIMarket Company Name, Ticker, Industry, else..
Caredx Inc   (NASDAQ: CDNA)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


 

Caredx Inc

CDNA's Financial Statements and Analysis



Caredx Inc reported in the third quarter of 2025 net earnings per share of $0.03 an improvement compare to net loss per share of $-0.14 recorded a year ago and an improvement compare to net loss per share of $-0.16 realized in previous quarter.


third quarter of 2025
Earnings Per Share Revenues
$ 0.03 $  100 Mill
$+0.17     $+17M     +20.72 %



Caredx Inc 's Revenue rose by 20.72 % in third quarter of 2025 (Sep 30 2025) year on year, to $100 million and advanced by 15.43 % sequentially.


Caredx Inc is

More on CDNA's Income Statement



Caredx Inc 's net income of $1.675 million in the third quarter of 2025 increased from net loss of $-7.408 million III. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-8.568 million recorded in previous quarter.

More on CDNA's Growth

Caredx Inc Inventories
Inventories grew by 47.06 % to $28 million from III. Quarter a year ago, sequentially inventories rose by 1.48 %. CDNA's Cash flow In the third quarter of 2025 company's net cash flow was $23 million

More on CDNA's Cash flow Statement


Caredx Inc does not pay out common stock dividend.

In trailing twelve-month period Caredx Inc earned $ 0.79 cash per share, on a free-cash flow basis 96.58 % of net earning per share.

Book value fell by -3.95 % sequentially to $5.79 per share.
Tangible Book value fell to $ 4.42 per share from $ 4.62.

Company repurchased 0.57 million shares or 1.05 % in Sep 30 2025.
Interest Coverage Ratio was 6.96.

• More on CDNA's Dividends

 Market Capitalization (Millions) 856
 Shares Outstanding (Millions) 54
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 358
 Net Income (TTM) (Millions $) 61
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 643




Caredx Inc does not pay out common stock dividend.

In trailing twelve-month period Caredx Inc had $ 0.79 cash flow per share, on a free-cash flow basis 96.58 % of net earning per share.

Book value fell by -3.95 % sequentially to $5.79 per share.
Tangible Book value fell to $ 4.42 per share from $ 4.62.

Company repurchased 0.57 million shares or 1.05 % in Sep 30 2025.
Interest Coverage Ratio was 6.96.

• More on CDNA's Balance Sheets

 Market Capitalization (Millions) 856
 Shares Outstanding (Millions) 54
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 358
 Net Income (TTM) (Millions $) 61
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 643
   


  News about Caredx Inc Earnings

Soft Top-line Growth at Caredx Inc in the Fiscal Period Ending March 31, 2024

Caredx Inc Shows Striking Improvement in Fiscal Year 2024 Results
Caredx Inc, the leading molecular diagnostics company, has reported a significant reduction in losses and an improvement in revenue for the fiscal year ending March 31, 2024. These positive financial results have caught the attention of investors, leading to a surge in the company's stock value over the past month.
According to the financial statement released by Caredx Inc, the company has successfully decreased its loss per share from $-0.44 to $-0.32 when compared to the previous year. Furthermore, the company's earnings per share (EPS) showed remarkable progress, improving from $-2.18 to $-0.32 per share in the previous reporting p...

Caredx Inc. Sees Double-Digit Revenue Decline Through Fiscal Year Ending December 31, 2023

The stock market can be a rollercoaster ride for investors, with its ups and downs and constant changes. However, it is important to remember that even in challenging times, there are always opportunities to be found. One company that has recently faced some setbacks is Caredx Inc. Despite reporting a rise in losses for the fourth quarter of 2023, there are several positive factors investors should consider.
In the financial report, Caredx Inc. disclosed a shortfall per share that inched up to $-2.18 from $-0.34. While this may seem concerning at first, it is important to note that this increase is primarily due to weak demand, rather than any fundamental issues with the company itself. It is crucial to ...

CDNA Reports Increased Deficit in Third Quarter 2023 Earnings Season compared to Last Year



Caredx Inc, a leading medical diagnostics company, has recently released its third-quarter earnings results for 2023. Unfortunately, the company's financial performance paints a bleak picture, with both earnings per share and revenue experiencing a decline compared to the previous year. This bearish article will analyze the company's poor financial performance, highlight its increasing net losses, and discuss the potential risks and challenges it may face in the near future.
Earnings Per Share Shows Minimal Improvement Amidst Worsening Deficit:
During the third quarter of 2023, the company's earnings deficit extended to $-0.43 per share, compared to $-0.32 per share during the same period t...

Caredx Inc Faces Financial Setback as Shortfall per Share Deepens, Threatening Future Growth



Caredx Inc recently released its financial results for the fiscal year ending June 30, 2023. The results reveal several interesting trends and figures that could potentially impact the company's future growth and prospects. This article delves into these findings and ponders how they might influence Caredx Inc in the coming months.
1. Increased Shortfall per Share:
Caredx Inc witnessed a rise in the shortfall per share, reaching $-0.46 compared to $-0.41 in the previous year. Moreover, compared to the prior financial reporting period, the shortfall grew from $-0.44 per share. This indicates that the company's profitability declined over the respective periods, potentially warranting a close...

Caredx Inc's Revenue Takes a Hit as Recent Fiscal Period Reveals a Decline

Caredx Inc, a healthcare c...


Date modified: 2025-11-11T17:26:43+00:00




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.